Advertisement
Screener

NOMAD POWER SOLUTIONS, INC. (NMAD) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

1.5 / 5 stars · 15/50 Roast Me

NOMAD POWER SOLUTIONS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

NOMAD POWER SOLUTIONS, INC. (NMAD) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 8.28 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-14

  • NOMAD POWER SOLUTIONS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 9.65M shares, a 379.89% increase year-over-year.
  • NOMAD POWER SOLUTIONS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 2.01M shares, a 40.28% increase year-over-year.
  • NOMAD POWER SOLUTIONS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 1.43M shares, a 120.12% increase year-over-year.
  • NOMAD POWER SOLUTIONS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 651.18K shares, a 89.99% decline year-over-year.
  • NOMAD POWER SOLUTIONS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 12.09M shares, a 709.21% increase from fiscal 2024.
  • NOMAD POWER SOLUTIONS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.49M shares, a 4.27% increase from fiscal 2023.
  • NOMAD POWER SOLUTIONS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 1.43M shares, a 119.70% increase from fiscal 2022.
  • NOMAD POWER SOLUTIONS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 652.43K shares, a 89.97% decline from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-308.28M shares
10-Q · filed 2026-08-14
2026-03-319.65M shares
10-Q · filed 2026-05-14
2025-12-3112.09M shares
10-K · filed 2026-03-31
2025-09-3012.31M shares
10-Q · filed 2025-11-12
2025-06-302.02M shares
10-Q · filed 2026-08-14
2025-03-312.01M shares
10-Q · filed 2026-05-14
2024-12-311.49M shares
10-K · filed 2026-03-31
2024-09-301.50M shares
10-Q · filed 2025-11-12
2024-06-301.49M shares
10-Q · filed 2025-08-07
2024-03-311.43M shares
10-Q · filed 2025-05-12
2023-12-311.43M shares
10-K · filed 2025-03-24
2023-09-301.56M shares
10-Q · filed 2024-11-12
2023-06-30691.18K shares
10-Q · filed 2024-08-08
2023-03-31651.18K shares
10-Q · filed 2024-05-09		6.51M shares
10-Q · filed 2023-05-10
2022-12-31652.43K shares
10-K · filed 2024-03-19		6.52M shares
10-K · filed 2023-03-29
2022-09-30745.45K shares
10-Q · filed 2023-11-09		7.45M shares
10-Q · filed 2022-11-08
2022-06-30745.45K shares
10-Q · filed 2023-08-09		7.45M shares
10-Q · filed 2022-08-10
2022-03-316.51M shares
10-Q · filed 2023-05-10
2021-12-316.51M shares
10-K · filed 2023-03-29
2021-09-306.31M shares
10-Q · filed 2022-11-08
2021-06-306.39M shares
10-Q · filed 2022-08-10
2021-03-315.51M shares
10-Q · filed 2022-05-11
2020-12-315.20M shares
10-K · filed 2022-03-21
2020-09-303.74M shares
10-Q · filed 2021-11-10		22.43M shares
10-Q · filed 2020-11-10
2020-06-303.54M shares
10-Q · filed 2021-08-10		21.23M shares
10-Q · filed 2020-08-10
2020-03-313.54M shares
10-Q · filed 2021-05-12		21.23M shares
10-Q · filed 2020-05-11
2019-12-313.54M shares
10-K · filed 2021-03-26		21.23M shares
10-K · filed 2020-03-25
2019-09-3021.43M shares
10-Q · filed 2020-11-10
2019-06-3020.93M shares
10-Q · filed 2020-08-10
2019-03-3121.13M shares
10-Q · filed 2020-05-11
2018-12-3121.13M shares
10-K · filed 2020-03-25
2018-09-3012.22M shares
10-Q · filed 2019-11-08
2018-06-3011.85M shares
10-Q · filed 2019-08-06
2018-03-3111.85M shares
10-Q · filed 2019-05-09
2017-12-3111.85M shares
10-K · filed 2019-03-25
2017-09-3011.63M shares
10-Q · filed 2018-11-08
2017-06-3012.97M shares
10-Q · filed 2018-08-02
2017-03-3112.97M shares
10-Q · filed 2018-04-27
2016-12-3112.97M shares
10-K · filed 2018-03-23
2016-09-3013.47M shares
10-Q · filed 2017-11-09
2016-06-3012.97M shares
10-Q · filed 2017-08-04
2016-03-3112.32M shares
10-Q · filed 2017-05-10
2015-12-3110.14M shares
10-K · filed 2017-03-29
2015-09-3010.44M shares
10-Q · filed 2016-11-04
2015-06-309.44M shares
10-Q · filed 2016-08-10
2015-03-3111.94M shares
10-Q · filed 2016-05-06
2014-12-319.78M shares
10-K · filed 2016-03-28
2014-09-3010.30M shares
10-Q · filed 2015-11-10
2014-06-3010.43M shares
10-Q · filed 2015-08-07
2014-03-3113.85M shares
10-Q · filed 2015-05-13
2013-12-319.98M shares
10-K · filed 2015-03-27
2013-09-3010.38M shares
10-Q · filed 2014-11-12
2013-06-3010.48M shares
10-Q · filed 2014-08-08
2013-03-3110.48M shares
10-Q · filed 2014-05-09
2012-12-3110.58M shares
10-K · filed 2014-03-21
2012-09-3010.70M shares
10-Q · filed 2013-11-07
2012-06-3010.52M shares
10-Q · filed 2013-08-05
2012-03-3116.60M shares
10-Q · filed 2013-05-09
2011-12-3116.70M shares
10-K · filed 2013-03-15
2011-09-3016.20M shares
10-Q · filed 2012-11-13
2011-06-3016.80M shares
10-Q · filed 2012-08-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
TALPHERA, INC. (TLPH)United States$0.060B
CalciMedica, Inc. (CALC)United States$0.061B-1.42
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Clene Inc. (CLNN)United States$0.054B-1.99
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Xilio Therapeutics, Inc. (XLO)United States$0.052B
Advertisement